Sally Shrapnel

Dr. Sally Shrapnel

Centre for Engineered Quantum Systems, University of Queensland, St Lucia, QLD 4072, Australia
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in New Journal of Physics
Verified
Journal Article
Open access
PDF file
FCFabio Costa
Fabio Costa
SSSally Shrapnel
Sally Shrapnel

13 April 2018 in New Journal of Physics
Verified
Journal Article
Open access
PDF file
SSSally Shrapnel
Sally Shrapnel
FCFabio Costa
Fabio Costa
GMGerard Milburn
Gerard Milburn
Despite the tremendous empirical success of quantum theory there is still widespread disagreement about what it can tell us about the nature of the world. A central question is whether the theory is about our knowledge of reality, or a direct statement about reality itself. Current interpretations of quantum theory, regardless of their stance on this question, regard the Born rule as fundamental and add an independent state-update (or "collapse") rule to describe how quantum states change upon measurement. In this paper we present an alternative perspective and derive a unified probability rule that subsumes both the Born rule and the collapse rule. We show that this more fundamental probability rule can provide a rigorous foundation for informational, or "knowledge-based", interpretations of quantum theory. Our result requires an assumption of instrument non-contextuality, a key notion that generalises previous approaches to non-contextuality. Therefore, the framework also permits one to consider non-contextuality in scenarios with arbitrary causal structure.

2 August 2024 in Journal of Medical Internet Research
Verified
Journal Article
Open access
ARAmir Kamel Rahimi
Amir Kamel Rahimi
OPOliver Pienaar
Oliver Pienaar
MGMoji Ghadimi
Moji Ghadimi
OCOliver J Canfell
Oliver J Canfell
JPJason Pole
Jason Pole
CSClair Sullivan
Clair Sullivan
Background: Efforts are underway to capitalize on the computational power of the data collected in electronic medical records (EMRs) to achieve a learning health system (LHS). Artificial intelligence (AI) in health care has promised to improve clinical outcomes, and many researchers are developing AI algorithms on retrospective data sets. Integrating these algorithms with real-time EMR data is rare. There is a poor understanding of the current enablers and barriers to empower this shift from data set–based use to real-time implementation of AI in health systems. Exploring these factors holds promise for uncovering actionable insights toward the successful integration of AI into clinical workflows. Objective: The first objective was to conduct a systematic literature review to identify the evidence of enablers and barriers regarding the real-world implementation of AI in hospital settings. The second objective was to map the identified enablers and barriers to a 3-horizon framework to enable the successful digital health transformation of hospitals to achieve an LHS. Methods: The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines were adhered to. PubMed, Scopus, Web of Science, and IEEE Xplore were searched for studies published between January 2010 and January 2022. Articles with case studies and guidelines on the implementation of AI analytics in hospital settings using EMR data were included. We excluded studies conducted in primary and community care settings. Quality assessment of the identified papers was conducted using the Mixed Methods Appraisal Tool and ADAPTE frameworks. We coded evidence from the included studies that related to enablers of and barriers to AI implementation. The findings were mapped to the 3-horizon framework to provide a road map for hospitals to integrate AI analytics. Results: Of the 1247 studies screened, 26 (2.09%) met the inclusion criteria. In total, 65% (17/26) of the studies implemented AI analytics for enhancing the care of hospitalized patients, whereas the remaining 35% (9/26) provided implementation guidelines. Of the final 26 papers, the quality of 21 (81%) was assessed as poor. A total of 28 enablers was identified; 8 (29%) were new in this study. A total of 18 barriers was identified; 5 (28%) were newly found. Most of these newly identified factors were related to information and technology. Actionable recommendations for the implementation of AI toward achieving an LHS were provided by mapping the findings to a 3-horizon framework. Conclusions: Significant issues exist in implementing AI in health care. Shifting from validating data sets to working with live data is challenging. This review incorporated the identified enablers and barriers into a 3-horizon framework, offering actionable recommendations for implementing AI analytics to achieve an LHS. The findings of this study can assist hospitals in steering their strategic planning toward successful adoption of AI.

24 October 2019
Verified
Book Chapter
Closed access
PDF file
KYKyle Young
Kyle Young
GBGareth Booth
Gareth Booth
BSBecks Simpson
Becks Simpson
RDReuben Dutton
Reuben Dutton
SSSally Shrapnel
Sally Shrapnel

20 April 2022 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
MWMarina Wainstein
Marina Wainstein
SMSamual MacDonald
Samual MacDonald
DFDaniel Fryer
Daniel Fryer
KYKyle Young
Kyle Young
VBValeria Balan
Valeria Balan
TGthe ISARIC Clinical Characterisation Group
the ISARIC Clinical Characterisation Group
Background: Acute kidney injury (AKI) is one of the most common and significant problems in patients with Coronavirus Disease 2019 (COVID-19). However, little is known about the incidence and impact of AKI occurring in the community or early in the hospital admission. The traditional Kidney Disease Improving Global Outcomes (KDIGO) definition can fail to identify patients for whom hospitalisation coincides with recovery of AKI as manifested by a decrease in serum creatinine (sCr). We hypothesised that an extended KDIGO (eKDIGO) definition, adapted from the International Society of Nephrology (ISN) 0by25 studies, would identify more cases of AKI in patients with COVID-19 and that these may correspond to community-acquired AKI (CA-AKI) with similarly poor outcomes as previously reported in this population. Methods and findings: All individuals recruited using the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC)–World Health Organization (WHO) Clinical Characterisation Protocol (CCP) and admitted to 1,609 hospitals in 54 countries with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection from February 15, 2020 to February 1, 2021 were included in the study. Data were collected and analysed for the duration of a patient’s admission. Incidence, staging, and timing of AKI were evaluated using a traditional and eKDIGO definition, which incorporated a commensurate decrease in sCr. Patients within eKDIGO diagnosed with AKI by a decrease in sCr were labelled as deKDIGO. Clinical characteristics and outcomes—intensive care unit (ICU) admission, invasive mechanical ventilation, and in-hospital death—were compared for all 3 groups of patients. The relationship between eKDIGO AKI and in-hospital death was assessed using survival curves and logistic regression, adjusting for disease severity and AKI susceptibility. A total of 75,670 patients were included in the final analysis cohort. Median length of admission was 12 days (interquartile range [IQR] 7, 20). There were twice as many patients with AKI identified by eKDIGO than KDIGO (31.7% versus 16.8%). Those in the eKDIGO group had a greater proportion of stage 1 AKI (58% versus 36% in KDIGO patients). Peak AKI occurred early in the admission more frequently among eKDIGO than KDIGO patients. Compared to those without AKI, patients in the eKDIGO group had worse renal function on admission, more in-hospital complications, higher rates of ICU admission (54% versus 23%) invasive ventilation (45% versus 15%), and increased mortality (38% versus 19%). Patients in the eKDIGO group had a higher risk of in-hospital death than those without AKI (adjusted odds ratio: 1.78, 95% confidence interval: 1.71 to 1.80, p-value < 0.001). Mortality and rate of ICU admission were lower among deKDIGO than KDIGO patients (25% versus 50% death and 35% versus 70% ICU admission) but significantly higher when compared to patients with no AKI (25% versus 19% death and 35% versus 23% ICU admission) (all p-values <5 × 10−5). Limitations include ad hoc sCr sampling, exclusion of patients with less than two sCr measurements, and limited availability of sCr measurements prior to initiation of acute dialysis. Conclusions: An extended KDIGO definition of AKI resulted in a significantly higher detection rate in this population. These additional cases of AKI occurred early in the hospital admission and were associated with worse outcomes compared to patients without AKI.

17 December 2018 in International Journal of Quantum Information
Verified
Journal Article
Closed access
PDF file
SSSally Shrapnel
Sally Shrapnel
FCFabio Costa
Fabio Costa
GMGerard Milburn
Gerard Milburn